BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8922527)

  • 1. Urokinase-type plasminogen activator regulates cranial neural crest cell migration in vitro.
    Agrawal M; Brauer PR
    Dev Dyn; 1996 Nov; 207(3):281-90. PubMed ID: 8922527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cranial neural crest cells synthesize and secrete a latent form of transforming growth factor beta that can be activated by neural crest cell proteolysis.
    Brauer PR; Yee JA
    Dev Biol; 1993 Jan; 155(1):281-5. PubMed ID: 8416842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic matrix metalloproteinase inhibitor decreases early cardiac neural crest migration in chicken embryos.
    Cai DH; Brauer PR
    Dev Dyn; 2002 Aug; 224(4):441-9. PubMed ID: 12203736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human gingival fibroblast migration promoted by platelet-derived growth factor on titanium is correlated with release of urokinase type plasminogen activator.
    Abiko Y; Arai J; Matsuzawa K; Inoue T; Shimono M; Kaku T
    Bull Tokyo Dent Coll; 1996 Aug; 37(3):113-8. PubMed ID: 9151567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase regulates embryonic cardiac cushion cell migration without converting plasminogen.
    Gorny KN; Brauer PR
    Anat Rec; 1999 Nov; 256(3):269-78. PubMed ID: 10521785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of elevated homocysteine on cardiac neural crest migration in vitro.
    Brauer PR; Rosenquist TH
    Dev Dyn; 2002 Jun; 224(2):222-30. PubMed ID: 12112474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
    Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
    Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
    Berger DH; O'Mahony CA; Sheng H; Shao J; Albo D; DuBois RN; Beauchamp RD
    Surgery; 2003 May; 133(5):568-79. PubMed ID: 12773985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR; Church FC
    Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells.
    Vincent VA; Löwik CW; Verheijen JH; de Bart AC; Tilders FJ; Van Dam AM
    Glia; 1998 Feb; 22(2):130-7. PubMed ID: 9537833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells.
    Sugimura M; Kobayashi H; Terao T
    Gynecol Oncol; 1994 Mar; 52(3):337-46. PubMed ID: 7512520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPA/plasmin system-mediated MMP-9 activation is implicated in bronchial epithelial cell migration.
    Legrand C; Polette M; Tournier JM; de Bentzmann S; Huet E; Monteau M; Birembaut P
    Exp Cell Res; 2001 Apr; 264(2):326-36. PubMed ID: 11262189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cranial neural crest adhesion in vitro and migration in vivo using integrin antisense oligonucleotides.
    Kil SH; Lallier T; Bronner-Fraser M
    Dev Biol; 1996 Oct; 179(1):91-101. PubMed ID: 8873756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR; Palmieri D; Twerdi CD; Church FC
    Exp Cell Res; 2004 Jun; 296(2):151-62. PubMed ID: 15149846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.